Aksakal Resat, Tonneaux Corentin, Uvyn Annemiek, Fossépré Mathieu, Turgut Hatice, Badi Nezha, Surin Mathieu, De Geest Bruno G, Du Prez Filip E
Polymer Chemistry Research Group, Centre of Macromolecular Chemistry (CMaC), Department of Organic and Macromolecular Chemistry, Faculty of Sciences, Ghent University 9000 Ghent Belgium
Laboratory for Chemistry of Novel Materials, Center of Innovation and Research in Materials and Polymers (CIRMAP), University of Mons-UMONS 7000 Mons Belgium
Chem Sci. 2023 May 22;14(24):6572-6578. doi: 10.1039/d3sc01507f. eCollection 2023 Jun 21.
Antibody-recruiting molecules represent a novel class of therapeutic agents that mediate the recruitment of endogenous antibodies to target cells, leading to their elimination by the immune system. Compared to single-ligand copies, macromolecular scaffolds presenting multiple copies of an antibody-binding ligand offer advantages in terms of increased complex avidity. In this study, we describe the synthesis of sequence-defined macromolecules designed for antibody recruitment, utilising dinitrophenol (DNP) as a model antibody-recruiting motif. The use of discrete macromolecules gives access to varying the spacing between DNP motifs while maintaining the same chain length. This characteristic enables the investigation of structure-dependent binding interactions with anti-DNP antibodies. Through solid-phase thiolactone chemistry, we synthesised a series of oligomers with precisely localised DNP motifs along the backbone and a terminal biotin motif for surface immobilisation. Utilising biolayer interferometry analysis, we observed that oligomers with adjacent DNP motifs exhibited enhanced avidity for anti-DNP antibodies. Molecular modelling provided insights into the structures and dynamics of the various macromolecules, shedding light on the accessibility of the ligands to the antibodies. Overall, our findings highlight that the use of sequence-defined macromolecules can contribute to our understanding of structure-activity relationships and provide insights for the design of novel antibody-recruiting therapeutic agents.
抗体招募分子代表了一类新型治疗剂,可介导内源性抗体向靶细胞的招募,从而导致它们被免疫系统清除。与单配体拷贝相比,呈现抗体结合配体多个拷贝的大分子支架在增加复合物亲和力方面具有优势。在本研究中,我们描述了利用二硝基苯酚(DNP)作为模型抗体招募基序设计的用于抗体招募的序列定义大分子的合成。使用离散大分子能够在保持相同链长的同时改变DNP基序之间的间距。这一特性使得能够研究与抗DNP抗体的结构依赖性结合相互作用。通过固相硫内酯化学,我们合成了一系列沿着主链具有精确定位的DNP基序和用于表面固定的末端生物素基序的寡聚物。利用生物层干涉分析,我们观察到具有相邻DNP基序的寡聚物对抗DNP抗体表现出增强的亲和力。分子建模为各种大分子的结构和动力学提供了见解,揭示了配体与抗体的可及性。总体而言,我们的研究结果突出表明,使用序列定义的大分子有助于我们理解构效关系,并为新型抗体招募治疗剂的设计提供见解。